Moffitt Cancer Center Logo
 

Lynn C. Moscinski, MD

Where You Are:
Lynn C. Moscinski, MD

Senior Member

"My focus is developing new biomarkers in hematologic malignancies using molecular diagnostics, immunohistochemistry and advanced flow cytometric analysis."

Office  (813) 745-3001

Education And Training
  • Fellow, Hospital of the University of Pennsylvania, 1986 - Hematopathology
  • Resident, University of Colorado Health Sciences Center, 1982 - Pathology
  • MD, Medical College of Wisconsin, 1981


  • Horna P, Pantazopoulos P, Lancet JE, Moscinski LC, Zhang L. Prominent hematogone hyperplasia in BCR-ABL1-positive chronic myelogenous leukemia: mimicking recurrent B-lymphoid blast crisis. Leuk Lymphoma. 2014 Feb. Pubmedid: 24304373.
  • Horna P, Deaver DM, Qin D, Moscinski LC, Sotomayor EM, Glass LF, Sokol L. Quantitative flow cytometric identification of aberrant T cell clusters in erythrodermic cutaneous T cell lymphoma. Implications for staging and prognosis. J Clin Pathol. 2013 Dec. Pubmedid: 24319102.
  • Lwin T, Zhao X, Cheng F, Zhang X, Huang A, Shah B, Zhang Y, Moscinski LC, Choi YS, Kozikowski AP, Bradner JE, Dalton WS, Sotomayor E, Tao J. A microenvironment-mediated c-Myc/miR-548m/HDAC6 amplification loop in non-Hodgkin B cell lymphomas. J Clin Invest. 2013 Nov;123(11):4612-4626. Pubmedid: 24216476. Pmcid: PMC3809771.
  • Mailloux AW, Zhang L, Moscinski L, Bennett JM, Yang L, Yoder SJ, Bloom G, Wei C, Wei S, Sokol L, Loughran TP, Epling-Burnette PK. Fibrosis and subsequent cytopenias are associated with basic fibroblast growth factor-deficient pluripotent mesenchymal stromal cells in large granular lymphocyte leukemia. J Immunol. 2013 Oct;191(7):3578-3593. Pubmedid: 24014875.
  • Setoodeh R, Schwartz S, Papenhausen P, Zhang L, Sagatys EM, Moscinski LC, Shao H. Double-hit mantle cell lymphoma with MYC gene rearrangement or amplification: a report of four cases and review of the literature. Int J Clin Exp Pathol. 2013 Jul;6(2):155-167. Pubmedid: 23330001. Pmcid: PMC3544229.
  • Zhang Y, Zhang L, Jin X, Zhao H, Hao X, Peker D, Wei S, Sokol L, Moscinski L. Bone marrow involvement as initial presentation of CD8 cytotoxic peripheral T-cell lymphoma with CD20 coexpression and relatively indolent clinical course. Leuk Lymphoma. 2013 May;54(5):1113-1116. Pubmedid: 23035635.
  • Zhang L, Sotomayor EM, Papenhausen PR, Shao H, Moscinski LC, Sandin RL, Caceres G, Valenica H, Malafa M, List AF, Sokol L. Unusual concurrence of T-cell large granular lymphocytic leukemia with Franklin disease (gamma heavy chain disease) manifested with massive splenomegaly. Leuk Lymphoma. 2013 Jan;54(1):205-208. Pubmedid: 22694793.
  • Zhang X, Zhao X, Fiskus W, Lin J, Lwin T, Rao R, Zhang Y, Chan JC, Fu K, Marquez VE, Chen-Kiang S, Moscinski LC, Seto E, Dalton WS, Wright KL, Sotomayor E, Bhalla K, Tao J. Coordinated silencing of MYC-mediated miR-29 by HDAC3 and EZH2 as a therapeutic target of histone modification in aggressive B-Cell lymphomas. Cancer Cell. 2012 Oct;22(4):506-523. Pubmedid: 23079660. Pmcid: PMC3973134.
  • Zhang X, Chen X, Lin J, Lwin T, Wright G, Moscinski LC, Dalton WS, Seto E, Wright K, Sotomayor E, Tao J. Myc represses miR-15a/miR-16-1 expression through recruitment of HDAC3 in mantle cell and other non-Hodgkin B-cell lymphomas. Oncogene. 2012 Jun;31(24):3002-3008. Pubmedid: 22002311. Pmcid: PMC3982396.
  • Mathew RA, Bennett JM, Liu JJ, Komrokji RS, Lancet JE, Naghashpour M, Messina JL, List AF, Moscinski LC, Zhang L. Cutaneous manifestations in CMML: Indication of disease acceleration or transformation to AML and review of the literature. Leuk Res. 2012 Jan;36(1):72-80. Pubmedid: 21782240.
  • Naghashpour M, Setoodeh R, Moscinski L, Bergier G, McCardle T, Glass F, Sokol L. Nonnecrobiotic necrobiotic xanthogranuloma as an initial manifestation of paraproteinemia and small lymphocytic lymphoma in a patient with Sjögren syndrome. Am J Dermatopathol. 2011 Dec;33(8):855-857. Pubmedid: 22042261.
  • Hu X, Moscinski LC. Cdc2: a monopotent or pluripotent CDK?. Cell Prolif. 2011 Jun;44(3):205-211. Pubmedid: 21535261.
  • Zhang L, Bennett JM, Zhang X, Moscinski L, Ibarz-Pinilla J, List AF, Komrokji R. Uncommon of the uncommon: low-grade myelodysplastic syndrome evolving into chronic myelogenous leukemia. J Clin Oncol. 2011 May;29(15):e434-e436. Pubmedid: 21149648.
  • Powers JJ, Dubovsky JA, Epling-Burnette PK, Moscinski L, Zhang L, Mustjoki S, Sotomayor EM, Pinilla-Ibarz JA. A molecular and functional analysis of large granular lymphocyte expansions in patients with chronic myelogenous leukemia treated with tyrosine kinase inhibitors. Leuk Lymphoma. 2011 Apr;52(4):668-679. Pubmedid: 21271862.
  • Sokol L, Caceres G, Volinia S, Alder H, Nuovo GJ, Liu CG, McGraw K, Clark JA, Sigua CA, Chen DT, Moscinski L, Croce CM, List AF. Identification of a risk dependent microRNA expression signature in myelodysplastic syndromes. Br J Haematol. 2011 Apr;153(1):24-32. Pubmedid: 21332710.
  • Lin J, Lwin T, Zhao JJ, Tam W, Choi YS, Moscinski LC, Dalton WS, Sotomayor EM, Wright KL, Tao J. Follicular dendritic cell-induced microRNA-mediated upregulation of PRDM1 and downregulation of BCL-6 in non-Hodgkin's B-cell lymphomas. Leukemia. 2011 Jan;25(1):145-152. Pubmedid: 20966935. Pmcid: PMC3083119.
  • Lwin T, Lin J, Choi YS, Zhang X, Moscinski LC, Wright KL, Sotomayor EM, Dalton WS, Tao J. Follicular dendritic cell-dependent drug resistance of non-Hodgkin lymphoma involves cell adhesion-mediated Bim down-regulation through induction of microRNA-181a. Blood. 2010 Dec;116(24):5228-5236. Pubmedid: 20841506. Pmcid: PMC3012540.
  • Wiranowska M, Ladd S, Moscinski LC, Hill B, Haller E, Mikecz K, Plaas A. Modulation of hyaluronan production by CD44 positive glioma cells. Int J Cancer. 2010 Aug;127(3):532-542. Pubmedid: 19957333. Pmcid: PMC3962665.
  • Zhao JJ, Lin J, Lwin T, Yang H, Guo J, Kong W, Dessureault S, Moscinski LC, Rezania D, Dalton WS, Sotomayor E, Tao J, Cheng JQ. microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma. Blood. 2010 Apr;115(13):2630-2639. Pubmedid: 20086245. Pmcid: PMC2852365.
  • Mourad AR, Kharfan-Dabaja MA, Benson K, Moscinski LC, Baz RC. Leptomeningeal myeloma as the sole manifestation of relapse: an unusual presentation. Am J Med Sci. 2010 Jan;339(1):81-82. Pubmedid: 19875952.
  • Pal R, Monaghan SA, Hassett AC, Mapara MY, Schafer P, Roodman GD, Ragni MV, Moscinski L, List A, Lentzsch S. Immunomodulatory derivatives induce PU.1 down-regulation, myeloid maturation arrest, and neutropenia. Blood. 2010 Jan;115(3):605-614. Pubmedid: 19965623.
  • Johns ME, Moscinski LC, Sokol L. Phenytoin-associated lymphoadenopathy mimicking a peripheral T-cell lymphoma. Mediterr J Hematol Infect Dis. 2010;2(2):e2010028. Pubmedid: 21415974. Pmcid: PMC3033141.
  • Montenegro DE, Franklin T, Moscinski LC, Zuckerman KS, Hu XT. TGFbeta inhibits GM-CSF-induced phosphorylation of ERK and MEK in human myeloid leukaemia cell lines via inhibition of phosphatidylinositol 3-kinase (PI3-k). Cell Prolif. 2009 Feb;42(1):1-9. Pubmedid: 19143758. Pmcid: PMC3928791.
  • Lwin T, Crespo LA, Wu A, Dessureault S, Shu HB, Moscinski LC, Sotomayor E, Dalton WS, Tao J. Lymphoma cell adhesion-induced expression of B cell-activating factor of the TNF family in bone marrow stromal cells protects non-Hodgkin's B lymphoma cells from apoptosis. Leukemia. 2009 Jan;23(1):170-177. Pubmedid: 18843286.
  • Epling-Burnette PK, Sokol L, Chen X, Bai F, Zhou J, Blaskovich MA, Zou J, Painter JS, Edwards TD, Moscinski L, Yoder JA, Djeu JY, Sebti S, Loughran TP, Wei S. Clinical improvement by farnesyltransferase inhibition in NK large granular lymphocyte leukemia associated with imbalanced NK receptor signaling. Blood. 2008 Dec;112(12):4694-4698. Pubmedid: 18791165. Pmcid: PMC2597136.
  • Lwin T, Hazlehurst LA, Dessureault S, Lai R, Bai W, Sotomayor E, Moscinski LC, Dalton WS, Tao J. Cell adhesion induces p27Kip1-associated cell-cycle arrest through down-regulation of the SCFSkp2 ubiquitin ligase pathway in mantle-cell and other non-Hodgkin B-cell lymphomas. Blood. 2007 Sep;110(5):1631-1638. Pubmedid: 17502456. Pmcid: PMC1975846.
  • Lwin T, Hazlehurst LA, Li Z, Dessureault S, Sotomayor E, Moscinski LC, Dalton WS, Tao J. Bone marrow stromal cells prevent apoptosis of lymphoma cells by upregulation of anti-apoptotic proteins associated with activation of NF-kappaB (RelB/p52) in non-Hodgkin's lymphoma cells. Leukemia. 2007 Jul;21(7):1521-1531. Pubmedid: 17476277.
  • Burnette PK, Bai F, Painter JS, Rollison DE, Salih HR, Krusch M, ZouJ, Ku E, Zhong B, Boulware D, Moscinski L, Wei S, Djeu JY, List AF. Reduced natural killer (NK) function associated with high-risk myelodysplastic syndrome (MDS) and reduced expression of activating NK receptors. Blood. 2007 Jun;109(11):4816-4824. Pubmedid: 17341666.
  • Lancet JE, List AF, Moscinski LC. Treatment of deletion 5q acute myeloid leukemia with lenalidomide. Leukemia. 2007 Mar;21(3):586-588. Pubmedid: 17230228.
  • Hu X, Cui D, Moscinski LC, Zhang X, Maccachero V, Zuckerman KS. TGFbeta regulates the expression and activities of G2 checkpoint kinases in human myeloid leukemia cells. Cytokine. 2007 Feb;37(2):155-162. Pubmedid: 17459720.
  • Cualing HD, Zhong E, Moscinski L. "Virtual flow cytometry" of immunostained lymphocytes on microscopic tissue slides: iHCFlow tissue cytometry. Cytometry B Clin Cytom. 2007 Jan;72(1):63-76. Pubmedid: 17133379.
  • Wu J, Cantor A, Moscinski L. beta2 Integrins are characteristically absent in acute promyelocytic leukemia and rapidly upregulated in vivo upon differentiation with all-trans retinoic acid. Leuk Res. 2007 Jan;31(1):49-57. Pubmedid: 16764927.
  • George P, Bali P, Annavarapu S, Scuto A, Fiskus W, Guo F, Sigua C, Sondarva G, Moscinski L, Atadja P, Bhalla K. Combination of the histone deacetylase inhibitor LBH589 and the hsp90 inhibitor 17-AAG is highly active against human CML-BC cells and AML cells with activating mutation of FLT-3. Blood. 2005 Feb;105(4):1768-1776. Pubmedid: 15514006.
  • Bali P, George P, Cohen P, Tao J, Guo F, Sigua C, Vishvanath A, Scuto A, Annavarapu S, Fiskus W, Moscinski L, Atadja P, Bhalla K. Superior activity of the combination of histone deacetylase inhibitor LAQ824 and the FLT-3 kinase inhibitor PKC412 against human acute myelogenous leukemia cells with mutant FLT-3. Clin Cancer Res. 2004 Aug;10(15):4991-4997. Pubmedid: 15297399.
  • George P, Bali P, Cohen P, Tao J, Guo F, Sigua C, Vishvanath A, Fiskus W, Scuto A, Annavarapu S, Moscinski L, Bhalla K. Cotreatment with 17-allylamino-demethoxygeldanamycin and FLT-3 kinase inhibitor PKC412 is highly effective against human acute myelogenous leukemia cells with mutant FLT-3. Cancer Res. 2004 May;64(10):3645-3652. Pubmedid: 15150124.
  • Guo F, Sigua C, Tao J, Bali P, George P, Li Y, Wittmann S, Moscinski L, Atadja P, Bhalla K. Cotreatment with histone deacetylase inhibitor LAQ824 enhances Apo-2L/tumor necrosis factor-related apoptosis inducing ligand-induced death inducing signaling complex activity and apoptosis of human acute leukemia cells. Cancer Res. 2004 Apr;64(7):2580-2589. Pubmedid: 15059915.
  • Johnson J, Moscinski L, Zuckerman K. Value of positron emission tomography scan in staging cancers, and an unusual presentation of acute myeloid leukemia. Case 3. Acute myeloid leukemia presenting with lytic bone lesions. J Clin Oncol. 2004;22(14):2968-2970. Pubmedid: 15254066.
  • Hazlehurst L, Enkemann S, Beam C, Argilagos R, Painter J, Shain K, Saporta S, Boulware L, Moscinski L, Alsina M, Dalton W. Genotypic and phenotypic comparisons of de novo and acquired melphalan resistance in an isogenic multiple myeloma cell line model. Cancer Res. 2003 Nov;63(22):7900-7906. Pubmedid: 14633719.
  • Nimmanapalli R, Fuino L, Bali P, Gasparetto M, Glozak M, Tao J, Moscinski L, Smith C, Wu J, Jove R, Atadja P, Bhalla K. Histone deacetylase inhibitor LAQ824 both lowers expression and promotes proteasomal degradation of Bcr-Abl and induces apoptosis of imatinib mesylate-sensitive or -refractory chronic myelogenous leukemia-blast crisis cells. Cancer Res. 2003 Aug;63(16):5126-5135. Pubmedid: 12941844.
  • McIlwain L, Sokol L, Moscinski L, Saba H. Acute myeloid leukemia mimicking primary testicular neoplasm. Presentation of a case with review of literature. Eur J Haematol. 2003 Apr;70(4):242-245. Pubmedid: 12656749.
  • Eason D, LeBron C, Coppola D, Moscinski L, Livingston S, Sutton E, Blanck G. Development of CD30+ lymphoproliferative disease in mice lacking interferon regulatory factor-1. Oncogene. 2003;22(40):6166-6176. Pubmedid: 13679855.
  • Huang M, Dorsey JF, Epling-Burnette PK, Nimmanapalli R, Landowski TH, Mora LB, Niu G, Sinibaldi D, Bai F, Kraker A, Yu H, Moscinski L, Wei S, Djeu J, Dalton WS, Bhalla K, Loughran TP, Wu J, Jove R. Inhibition of Bcr-Abl kinase activity by PD180970 blocks constitutive activation of Stat5 and growth of CML cells. Oncogene. 2002 Dec;21(57):8804-8816. Pubmedid: 12483533.
  • Hu X, Janssen WE, Moscinski LZC, Bryington M, Dangsupa A, Rezai-Zadeh N, Babbin BA, Zuckerman KS. An IkappaBalpha inhibitor causes leukemia cell death through a p38 MAP kinase-dependent, NF-kappaB-independent mechanism. Cancer Res. 2001 Aug;61(16):6290-6296. Pubmedid: 11507084.
  • Landowski T, Moscinski L, Burke R, Buyuksal I, Painter J, Goldstein S, Dalton W. CD95 antigen mutations in hematopoietic malignancies. Leuk Lymphoma. 2001;42(5):835-846. Pubmedid: 11697638.
  • Hu X, Moscinski L, Valkov N, Fisher A, Hill R, Zuckerman K. Prolonged activation of the mitogen-activated protein kinase pathway is required for macrophage-like differentiation of a human myeloid leukemic cell line. Cell Growth Differ. 2000 Apr;11(4):191-200. Pubmedid: 10775036.
  • Wiranowska M, Rojiani A, Gottschall P, Moscinski L, Johnson J, Saporta S. CD44 expression and MMP-2 secretion by mouse glioma cells: effect of interferon and anti-CD44 antibody. Anticancer Res. 2000;20(6B):4301-4306. Pubmedid: 11205262.
  • Hu X, Moscinski LC, Zuckerman KS. Transforming growth factor beta inhibits growth of more differentiated myeloid leukemia cells and retinoblastoma protein phosphorylation at serine 795. Exp Hematol. 1999 Apr;27(4):605-614. Pubmedid: 10210318.
  • Mora L, Moscinski L, Diaz J, Blair P, Cantor A, Pow-Sang J. Stage B prostate cancer: correlation of DNA ploidy analysis with histological and clinical parameters. Cancer Control. 1999;6(6):587-591. Pubmedid: 10756390.
  • Falcone R, Landowski TH, Oshiro MM, Turkson J, Levitzki A, Savino R, Ciliberto G, Moscinski L, Fernandez-Luna JL, Nunez G, Dalton WS, Jove R. Constitutive activation of STAT3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity. 1999;10(1):105-115. Pubmedid: 10023775.
  • Hu X, Moscinski L, Hill B, Chen Q, Wu J, Fisher A, Zuckerman K. Characterization of a unique factor-independent variant derived from human factor-dependent TF-1 cells: a transformed event. Leuk Res. 1998;22:817-826. Pubmedid: 9716013.
  • Garcia E, Sandin R, Greene J, Baekey P, Walling A, Letson G, Choy J, Nicosia S, Moscinski L. Infections of the leg which mimic malignancy. Infect Med. 1998;15(8):557-567. Pubmedid: noPMID.
  • Quiroz ES, Castellano CM, Greene JN, Sandin RL, Moscinski LC. Toxoplasmic Lymphadenopathy Clinically Presenting as Lymphoma. Cancer Control. 1997 Oct;4(5):434-439. Pubmedid: 10763053.
  • Maurtua MA, Moscinski LC, Messina J, Miller L, Ballester OF. Type III hypersensitivity reaction with the use of interferon-alpha. Am J Hematol. 1997 May;55(1):53-54. Pubmedid: 9136924.
  • Ballester O, Moscinski L, Fields K, Hiemenz J, Zorsky P, Goldstein S, Saba H, Spiers A, Kronish L, Sullivan P, Elfenbein G. Dexamethasone, cyclophosphamide, idarubicin and etoposide (DC-IE): a novel, intensive induction chemotherapy regimen for patients with high-risk multiple myeloma. Brit J Haematol. 1997 Mar;96(4):746-748. Pubmedid: 9074417.
  • Crucian B, Moscinski L, Androlewicz M, Ballester O, Widen R, Yu H. Assessment of intracellular TAP-1 and TAP-2 in conjunction with surface MHC class I in plasma cells from patients with multiple myeloma. Br J Haematol. 1997;98(2):426-432. Pubmedid: 9266943.
  • Fields K, Elfenbein G, Trudeau W, Perkins J, Janssen W, Moscinski L. Clinical significance of bone marrow metastases as detected using the polymerase chain reaction in patients with breast cancer undergoing high-dose chemotherapy and autologous bone marrow transplantation. J Clin Oncol. 1996 Jun;14(6):1868-1876. Pubmedid: 8656255.
  • Moscinski LW, Pendergrass TW, Weiss A, Hvizdala E, Buckley KS, Kalina RE. Recommendations for the use of routine bone marrow aspiration and lumbar punctures in the follow-up of patients with retinoblastoma. J Pediatr Hematol Oncol. 1996 May;18(2):130-134. Pubmedid: 8846123.
  • Moscinski L, Trudeau W, Fields K, Elfenbein G. High-sensitivity detection of minimal residual breast carcinoma using the polymerase chain reaction and primers for cytokeratin 19. Diagn Mol Pathol. 1996;5(3):173-180. Pubmedid: 8866230.
  • Garland L, Ballester O, Vasey F, Benson K, Moscinski L, Farmelo M, Rodriguez M, Rapaport D. Multiple myeloma in women with silicone breast implants. Serum immunoglobulin and interleukin-6 studies in women at risk. Curr Top Microbiol Immunol. 1996;361-366. Pubmedid: 8565578.
  • Hu X, Moscinski L, Hill B, Zuckerman K. 1996;3353.
  • Gleeson N, Hill B, Moscinski L, Mark J, Roberts W, Hoffman M, Fiorica J, Cavanagh D. Urokinase plasminogen activator in ovarian cancer. Eur J Gynaecol Oncol. 1996;18(2):110-113. Pubmedid: 8654466.
  • Williams L, Moscinski LC, Medveczky PG. Immunoglobulin germline mu transcripts in acute myelogenous leukemia cells vary in splicing pattern and are heterogeneous. Leukemia. 1995 Dec;9(12):2016-2022. Pubmedid: 8609711.
  • Fields K, Elfenbein G, Perkins J, Perkins J, Moscinski L. High dose versus standard dose chemotherapy for the treatment of breast cancer. A review of current concepts. Ann Ny Acad Sci. 1995 Dec;770:288-304. Pubmedid: 8597367.
  • Agaliotis D, Papenhausen P, Moscinski L, Elfenbein G. Case report of spontaneous remission of cytogenetic relapse of chronic myelogenous leukemia suggestive of progression to blast crisis after allogeneic bone marrow transplantation. Ann Hematol. 1995 Jan;70(1):37-41. Pubmedid: 7827205.
  • Benaim E, Hvizdala E, Papenhausen P, Moscinski L. Spontaneous remission in monosomy 7 myelodysplastic syndrome. Br J Haematol. 1995;89(4):947-948. Pubmedid: 7772545.
  • Alkan S, Morgan M, Sandin R, Moscinski L, Ross C. Cat-scratch disease: a dual etiologic role for afipia felis and rochalimaea henselae. Lancet. 1995;345:385-385. Pubmedid: 7531265.
  • Moscinski L, Hill B. Molecular cloning of a novel myeloid granule protein. J Cell Biochem. 1995;58:1-12. Pubmedid: 8749713.
  • Alkan S, Schnitzer B, Thompson J, Moscinski L, Ross C. Cyclin D1 protein expression in mantle cell lymphoma. Ann Oncol. 1995;6:567-570. Pubmedid: 8573535.
  • Spiers A, Saba H, Ballester O, Moscinski L, Morgan M, Williams E. Purple people with lymphoid neoplasms: a new clinical andpathological syndrome. Hematol Rev. 1995;9:197-204. Pubmedid: noPMID.
  • Moscinski L, Ballester O. Recent progress in multiple myeloma. Hematol Oncol. 1994;12:111-123.
  • Ballester O, Moscinski L, Lyman G, Chaney J, Saba H, Spiers A, Klein C. High levels of interleukin-6 are associated with low tumor burden and low growth fraction in multiple myeloma. Blood. 1994;83(7):1903-1908.
  • Saba H, Nawab U, Nadeem S, Cosgrove D, Moscinski L, Spiers A, Balducci L, Lyman G, Zuckerman K. 1994;624a.
  • Wang X, Heller R, Cruse C, VanVoorhis N, Glass L, Fenske N, Berman C, Leo-Messina J, Rapaport D, Wells K, DeConti R, Moscinski L, Stankard C, Puleo C, Reintgen D. Detection of submicroscopic lymph node metasases with polymerase chain reaction in patients with malignant melanoma. Ann Surg. 1994;220:768-774.
  • Spiers A, Saba H, Vieson K, Ballester O, Moscinski L, Dinwoodie W. Mycosis fungoides and Sezary syndrome: treatment with carboplatin and etoposide by continuous intravenous infusion. Blood. 1994;84:169a-169a.
  • Greene J, Sandin R, Fields K, Moscinski L, Beatty A, Pow-Sang J, Elfenbein G. Hemorrhagic cystitis in bone marrow transplant patients: is it an infection or chemotherapy toxicity?. Cancer Control. 1994;1(4):411-415.
  • Ballester O, Agaliotis D, Moscinski L, Fields K, Hiemenz J, Zorsky P, Goldstein S, Saba H, Spiers A. 1994;209.
  • Williams L, Moscinski LC. Sterile transcription of immunoglobulin/T-cell receptor genes and other evidence of early lymphoid differentiation in acute myelogenous leukemia. Leukemia. 1993 Sep;7(9):1423-1431. Pubmedid: 8371592.
  • Ballester O, Moscinski L, Spiers A, Balducci L. Non-Hodgkin's lymphoma in the older person: a review. J Am Geriatr Soc. 1993;41:1245-1254.
  • Williams L, Moscinski L. Sterile transcription of immunoglobulin/T-cell receptor genes and other evidence of early lymphoid differentiation in acute myelogenous leukemia. Leukemia. 1993;7(9):1423-1431.
  • Fields K, Moscinski L, Hebel D, Perkins J, Elfenbein G. 1993;144.
  • Virgilio J, Moscinski L, Ballester O, Corrado C, Guida C, Balducci L, Saba H. Acute lymphoblastic leukemia (ALL) in elderly patients. Hematol Oncol. 1993;11(3):121-126.
  • Moscinski L, Naylor P, Oliver J, Goldstein A. Thymosin (beta)4 potentiates the action of human granulocyte-macrophage colony-stimulating factor on bone marrow proliferation. Immunopharmacology. 1993;26:83-92.
  • Gupta S, Spiers A, Saba H, Moscinski L, Lyman G, Diaz J, Trotti, III A, Ridley M, Endicott J, Sanderson R. Extranodal lymphomas of the head and neck (ELHN): A six-year survey. Blood. 1993;82:2245-2245.
  • Ballester O, Saba H, Moscinski L, Nelson R, Foulis P. Pure red cell aplasia: treatment with intravenous immunoglobulin concentrate. Semin Hematol. 1992;29:106-108.
  • Ballester O, Moscinski L, Morris D, Balducci L. Acute myelogenous leukemia in the elderly. J Am Geriatr Soc. 1992;40:277-284.
  • Ballester O, Moscinski L, Lyman G, Chaney J, Saba H, Spiers A, Klein C. Interleukin-6: a growth factor or a differentiation factor for multiple myeloma. Blood. 1992;80:483-483.
  • Moscinski L, Kasnic G, Saker A. The significance of an elevated serum lysozyme in acute myelogenous leukemia with eosinophilia. Am J Clin Pathol. 1992;97:195-201.
  • Flannery MT, Wallach PM, Espinoza LR, Dohrenwend MP, Moscinski LC. A case of the eosinophilia-myalgia syndrome associated with use of an L-tryptophan product. Ann Intern Med. 1990 Feb;112(4):300-301. Pubmedid: 2297207.
  • Jaffe BD, Sabath DE, Johnson GD, Moscinski LC, Johnson KR, Rovera G, Nauseef WM, Prystowsky MB. Myeloperoxidase and oncogene expression in GM-CSF induced bone marrow differentiation. Oncogene. 1988 Feb;2(2):167-174. Pubmedid: 2835725.
  • Stork LC, Ambruso DR, Wallner SF, Sambrano JE, Moscinski LC, Wilson HL, McCabe ER. Pancytopenia in propionic acidemia: hematologic evaluation and studies of hematopoiesis in vitro. Pediatr Res. 1986 Aug;20(8):783-788. Pubmedid: 3737292.
  • Trimaldi J, Carballido EM, Bowers JW, Anguiano AL, Zhang ZJ, Shah BD, Bruno S, List AF, Moscinski LC, Grady T, Agosti SJ, Kang L, Zhang L. B-Lymphoblastic Leukemia/Lymphoma Associated with t(8;13)(p11;q12)/ ZMYM2 (ZNF198)-FGFR1 : Rare Case and Review of the Literature. Acta Haematol. 2013 Apr;130(3):127-134. Pubmedid: 23594707.
  • Naghashpour M, Lancet J, Moscinski L, Zhang L. Mixed phenotype acute leukemia with t(11;19)(q23;p13.3)/ MLL-MLLT1(ENL), B/T-lymphoid type: A first case report. Am J Hematol. 2010 Jun;85(6):451-454. Pubmedid: 20513125.
  • Fields K, Partyka J, Elfenbein G, Trudeau W, Kronish L, Perkins J, Moscinski L. Minimal residual disease in the bone marrow of patients with breast cancer undergoing bone marrow transplant: prognostic significance. In: Dicke K, Keating A, eds. Autologous Blood and Marrow Transplantation, Proceedings of the 8th International Symposium. Charlottesville, VA: Carden Jennings; 1997;305-312.
  • Moscinski L, Braylan R. Interpretation of modern diagnostic techniques in lymphoma. In: Rose N, De Macario E, Fahey J, Friedman H, et al, eds. Manual of Clinical Laboratory Immunology. 4th ed. Washington, DC: American Society For Microbiology Press; 1992;298-305.
  • Moscinski LC, Naylor PH, Oliver J, Goldstein AL. Thymosin beta 4 synergizes with human granulocyte-macrophage colony-stimulating factor in maintaining bone marrow proliferation. Immunopharmacology. 26(1):83-92. Pubmedid: 8407287.
  • Garland L, Ballester O, Vasey F, Benson K, Moscinski L, Farmelo J, Rodriguez M, Rapaport D. Immunology of Silicones. In: Potter M, Rose N, eds. Multiple myeloma in women with silicone breast implants. Serum immunoglobulin and interleukin-6 studies in women at risk. Berlin. Springer; 1996;361-366.
  • Fields K, Elfenbein G, Perkins J, Moscinski L. High dose versus standard dose chemotherapy for the treatment of breast cancer: a review of current concepts. In: Sackstein R, Janssen W, Elfenbein G, et al, eds. Annals of the New York Academy of Sciences. New York, NY: 1995;288-304.
TOOLS:   Font Size small font resizer separator font resizer separator big font resizer